In This Issue.
- Published in:
- International Immunology, 2021, v. 33, n. 1, p. 5, doi. 10.1093/intimm/dxaa074
- Publication type:
- Article
Works matching IS 09538178 AND DT 2021 AND VI 33 AND IP 1
Results: 6
1
2
P2X receptor agonist enhances tumor-specific CTL responses through CD70<sup>+</sup> DC-mediated T<sub>h</sub>17 induction.
- Published in:
- International Immunology, 2021, v. 33, n. 1, p. 49, doi. 10.1093/intimm/dxaa068
- By:
- Publication type:
- Article
3
Organized immune cell interactions within tumors sustain a productive T-cell response.
- Published in:
- International Immunology, 2021, v. 33, n. 1, p. 27, doi. 10.1093/intimm/dxaa057
- By:
- Publication type:
- Article
4
Newly emerged immunogenic neoantigens in established tumors enable hosts to regain immunosurveillance in a T-cell-dependent manner.
- Published in:
- International Immunology, 2021, v. 33, n. 1, p. 39, doi. 10.1093/intimm/dxaa049
- By:
- Publication type:
- Article
5
Immune metabolism in PD-1 blockade-based cancer immunotherapy.
- Published in:
- International Immunology, 2021, v. 33, n. 1, p. 17, doi. 10.1093/intimm/dxaa046
- By:
- Publication type:
- Article
6
Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.
- Published in:
- International Immunology, 2021, v. 33, n. 1, p. 7, doi. 10.1093/intimm/dxaa037
- By:
- Publication type:
- Article